Combination therapy with clindamycin and rifampicin is effective for hidradenitis suppurativa

被引：0
|
作者：
Mendonca, C [1 ]
Griffiths, CEM [1 ]
机构：
[1] Univ Manchester, Hope Hosp, Manchester, Lancs, England
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P47 / P47
页数：1
相关论文
共 50 条
  • [21] Effectiveness of doxycycline and rifampicin combination-therapy in hidradenitis suppurativa: a descriptive prospective study
    Verdaguer Faja, Julia
    Mora-Fernandez, Veronica
    Bassas-Vila, Julio
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 88 - 88
  • [22] Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes
    Pascual, J. C.
    Schneller-Pavelescu, L.
    Vergara-de-Caso, E.
    Martorell, A.
    Romani, J.
    Lazaro, M.
    Vilarrasa, E.
    Diaz Ley, B.
    Vazquez-Osorio, I.
    Segura-Palacios, J. M.
    Azana, J. M.
    Gonzalez-Lopez, M.
    Canueto, J.
    Molina-Leyva, A.
    Leiva-Salinas, M.
    Navarro-Trivino, F. J.
    Sanchez-Paya, J.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 : 43 - 44
  • [23] Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic
    Albrecht, J.
    Baine, P. A.
    Ladizinski, B.
    Jemec, G. B.
    Bigby, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 749 - 755
  • [24] Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes
    Schneller-Pavelescu, Luca
    Vergarade Caso, Eduardo
    Martorell, Antonio
    Romani, Jorge
    Lazaro, Mireya
    Vilarrasa, Eva
    Diaz-Ley, Blanca
    Vazquez-Osorio, Igor
    Segura Palacios, Juan Manuel
    Manuel Azana, Jose
    Gonzalez-Lopez, Marcos A.
    Canueto, Javier
    Molina-Leyva, Alejandro
    Leiva-Salinas, Maria
    Jose Navarro-Trivino, Francisco
    Sanchez-Paya, Jose
    Pascual, Jose C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (05) : 1455 - 1457
  • [25] Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa"
    Martora, Fabrizio
    Potestio, Luca
    Battista, Teresa
    Megna, Matteo
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (08) : e735 - e736
  • [26] Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients
    Delaunay, J.
    Villani, A. P.
    Guillem, P.
    Tristan, A.
    Boibieux, A.
    Jullien, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : E15 - E16
  • [27] Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes''
    Marasca, Claudio
    Masar, Anna
    Annunziata, Maria Carmela
    Fattore, Davide
    Fabbrocini, Gabriella
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : E269 - E269
  • [28] TOPICAL TREATMENT OF HIDRADENITIS SUPPURATIVA WITH CLINDAMYCIN
    CLEMMENSEN, OJ
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1983, 22 (05) : 325 - 328
  • [29] Short-term intravenous clindamycin accelerates the benefit of oral clindamycin-rifampicin treatment in hidradenitis suppurativa (HS)
    Kristandt, A.
    Nikolakis, G.
    Hauptmann, M.
    Becker, M.
    Zouboulis, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S159 - S159
  • [30] Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa - acne inversa in paediatric age: a prospective study
    Toni, G.
    Forconi, R.
    Bettoli, V.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 : 13 - 14
12345